H2 Water Slows Tumor Growth and Inhibits Breast Cancer CellsScientific Research
original title: Electrochemically Reduced Water Delays Mammary Tumors Growth in Mice and Inhibits Breast Cancer Cells Survival In Vitro
Giovanni Vanni Frajese, Monica Benvenuto, Rosanna Mattera, Saverio Giampaoli, Elena Ambrosin, Roberta Bernardini, Maria Gabriella Giganti, Loredana Albonici, Ivan Dus, Vittorio Manzari, Andrea Modesti, Maurizio Mattei, Roberto Bei
-
Abstract:
Electrochemical reduced water (ERW) has been proposed to have beneficial effects on human health due to its rich content of H 2 and the presence of platinum nanoparticles with antioxidant effects. Many studies have demonstrated that ERW scavenging properties are able to reduce the damage caused by oxidative stress in different experimental models. Although few in vivo studies have been reported, it has been demonstrated that ERW may display anticancer effects by induction of tumor cells apoptosis and reduction of both angiogenesis and inflammation. In this study, we show that ERW treatment of MCF-7, MDA-MB-453, and mouse (TUBO) breast cancer cells inhibited cell survival in a time-dependent fashion. ERW decreased ErbB2/ neu expression and impaired pERK1/ERK2 and AKT phosphorylation in breast cancer cells. In addition, ERW treatment induced apoptosis of breast cancer cell lines independently of the status of p53 and ER and PR receptors. Our in vivo results showed that ERW treatment of transgenic BALB- neu T mice delayed the development of mammary tumors compared to the control. In addition, ERW induced a significant prolongation of tumor-free survival and a reduction in tumor multiplicity. Overall, these results suggest a potential beneficial role of ERW in inhibiting cancer cells growth.
References
S. Shirahata, T. Hamasaki, and K. Teruya, “Advanced research on the health benefit of reduced water,” Trends in Food Science & Technology, vol. 23, no. 2, pp. 124–131, 2012.
View at: Publisher Site | Google Scholar
S. Giampaoli, F. Valeriani, G. Gianfranceschi et al., “Hydrogen sulfide in thermal spring waters and its action on bacteria of human origin,” Microchemical Journal, vol. 108, pp. 210–214, 2013.
View at: Publisher Site | Google Scholar
S. Shirahata, Y. Li, T. Hamasaki et al., “Redox regulation by reduced water as active hydrogen donors and intracellular ROS scavengers for prevention of type 2 diabetes,” in Cell Technology for Cell Products, E. Smith, Ed., pp. 99–101, Springer, Dordrecht, Netherlands, 2007.
View at: Publisher Site | Google Scholar
Y. Li, T. Nishimura, K. Teruya et al., “Protective mechanism of reduced water against alloxan-induced pancreatic beta-cell damage: Scavenging effect against reactive oxygen species,” Cytotechnology, vol. 40, pp. 139–149, 2002.
View at: Google Scholar
T. Kashiwagi, H. Yan, T. Hamasaki et al., “Electrochemically Reduced Water Protects Neural Cells from Oxidative Damage,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 869121, 18 pages, 2014.
View at: Publisher Site | Google Scholar
T. Hamasaki, T. Kashiwagi, T. Imada et al., “Kinetic analysis of superoxide anion radical-scavenging and hydroxyl radical-scavenging activities of platinum nanoparticles,” Langmuir, vol. 24, no. 14, pp. 7354–7364, 2008.
View at: Publisher Site | Google Scholar
M. Kajita, K. Hikosaka, M. Iitsuka, A. Kanayama, N. Toshima, and Y. Miyamoto, “Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide,” Free Radical Research, vol. 41, no. 6, pp. 615–626, 2007.
View at: Publisher Site | Google Scholar
T. Hamasaki, G. Harada, N. Nakamichi et al., “Electrochemically reduced water exerts superior reactive oxygen species scavenging activity in HT1080 cells than the equivalent level of hydrogen-dissolved water,” PLoS ONE, vol. 12, no. 2, Article ID e0171192, 2017.
View at: Publisher Site | Google Scholar
S. Shirahata, S. Kabayama, M. Nakano et al., “Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage,” Biochemical and Biophysical Research Communications, vol. 234, no. 1, pp. 269–274, 1997.
View at: Publisher Site | Google Scholar
M. Oda, K. Kusumoto, K. Teruya et al., “Electrolyzed and natural reduced water exhibit insulin-like activity on glucose uptake into muscle cells and adipocytes,” in Animal cell technology: products from cells, A. Bernard, B. Griffiths, W. Noé, and F. Wurm, Eds., pp. 425–427, Springer, Dordrecht, 1999.
View at: Google Scholar
D. Jin, S. H. Ryu, H. W. Kim et al., “Anti-diabetic effect of alkaline-reduced water on OLETF rats,” Bioscience, Biotechnology, and Biochemistry, vol. 70, no. 1, pp. 31–37, 2006.
View at: Publisher Site | Google Scholar
M.-J. Kim, K. H. Jung, Y. K. Uhm, K.-H. Leem, and H. K. Kim, “Preservative effect of electrolyzed reduced water on pancreatic β-cell mass in diabetic db/db mice,” Biological & Pharmaceutical Bulletin, vol. 30, no. 2, pp. 234–236, 2007.
View at: Publisher Site | Google Scholar
M.-J. Kim and H. K. Kim, “Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice,” Life Sciences, vol. 79, no. 24, pp. 2288–2292, 2006.
View at: Publisher Site | Google Scholar
I. Ohsawa, M. Ishikawa, K. Takahashi et al., “Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals,” Nature Medicine, vol. 13, no. 6, pp. 688–694, 2007.
View at: Publisher Site | Google Scholar
N. Kamimura, K. Nishimaki, I. Ohsawa, and S. Ohta, “Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice,” Obesity, vol. 19, no. 7, pp. 1396–1403, 2011.
View at: Publisher Site | Google Scholar
G. Song, C. Zong, Z. Zhang et al., “Molecular hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor-knockout mice,” Free Radical Biology & Medicine, vol. 87, pp. 58–68, 2015.
View at: Publisher Site | Google Scholar
T. Yokota, N. Kamimura, T. Igarashi, H. Takahashi, S. Ohta, and H. Oharazawa, “Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina,” Clinical & Experimental Ophthalmology, vol. 43, no. 6, pp. 568–577, 2015.
View at: Publisher Site | Google Scholar
J. Yu, W. Zhang, R. Zhang et al., “Molecular hydrogen attenuates hypoxia/reoxygenation injury of intrahepatic cholangiocytes by activating Nrf2 expression,” Toxicology Letters, vol. 238, no. 3, pp. 11–19, 2015.
View at: Publisher Site | Google Scholar
Y. Zhai, X. Zhou, Q. Dai, Y. Fan, and X. Huang, “Hydrogen-rich saline ameliorates lung injury associated with cecal ligation and puncture-induced sepsis in rats,” Experimental and Molecular Pathology, vol. 98, no. 2, pp. 268–276, 2015.
View at: Publisher Site | Google Scholar
J. Ye, Y. Li, T. Hamasaki et al., “Inhibitory effect of electrolyzed reduced water on tumor angiogenesis,” Biological & Pharmaceutical Bulletin, vol. 31, no. 1, pp. 19–26, 2008.
View at: Publisher Site | Google Scholar
C.-F. Tsai, Y.-W. Hsu, W.-K. Chen, Y.-C. Ho, and F.-J. Lu, “Enhanced induction of mitochondrial damage and apoptosis in human leukemia HL-60 cells due to electrolyzed-reduced water and glutathione,” Bioscience, Biotechnology, and Biochemistry, vol. 73, no. 2, pp. 280–287, 2009.
View at: Publisher Site | Google Scholar
Y. Saitoh, H. Okayasu, L. Xiao, Y. Harata, and N. Miwa, “Neutral pH hydrogen-enriched electrolyzed water achieves tumor-preferential clonal growth inhibition over normal cells and tumor invasion inhibition concurrently with intracellular oxidant repression,” Oncology Research : Featuring Preclinical and Clinical Cancer Therapeutics, vol. 17, no. 6, pp. 247–255, 2008.
View at: Publisher Site | Google Scholar
R. Nishikawa, K. Teruya, Y. Katakura et al., “Electrolyzed reduced water supplemented with platinum nanoparticles suppresses promotion of two-stage cell transformation,” Cytotechnology, vol. 47, no. 1-3, pp. 97–105, 2005.
View at: Publisher Site | Google Scholar
K. Boggio, G. Nicoletti, E. Di Carlo et al., “Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of HER-2/neu transgenic mice,” The Journal of Experimental Medicine, vol. 188, no. 3, pp. 589–596, 1998.
View at: Publisher Site | Google Scholar
S. Rovero, A. Amici, E. Di Carlo et al., “DNA vaccination against rat Her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice,” The Journal of Immunology, vol. 165, no. 9, pp. 5133–5142, 2000.
View at: Publisher Site | Google Scholar
L. Masuelli, M. Benvenuto, E. Di Stefano et al., “Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line,” Oncotarget , vol. 8, no. 21, pp. 34405–34422, 2017.
View at: Google Scholar
L. Masuelli, E. Di Stefano, M. Fantini et al., “Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas,” Oncotarget , vol. 5, no. 21, pp. 10745–10762, 2014.
View at: Publisher Site | Google Scholar
M. Benvenuto, P. Sileri, P. Rossi et al., “Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients,” Journal of Translational Medicine, vol. 13, no. 1, article 101, 2015.
View at: Publisher Site | Google Scholar
L. Masuelli, M. Benvenuto, and M. Fantini, “Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice,” Journal of BIOLOGICAL REGULATORS & Homeostatic Agents, vol. 27, pp. 105–119, 2013.
View at: Google Scholar
L. Masuelli, A. Budillon, L. Marzocchella et al., “Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α–β catenins complex and multiple erbb receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas,” Journal of Cellular Physiology, vol. 227, no. 9, pp. 3344–3353, 2012.
View at: Publisher Site | Google Scholar
L. Masuelli, L. Marzocchella, C. Focaccetti et al., “Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis,” Frontiers in Bioscience, vol. 17, no. 2, pp. 498–508, 2012.
View at: Publisher Site | Google Scholar
R. M. Neve, K. Chin, J. Fridlyand et al., “A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes,” Cancer Cell, vol. 10, no. 6, pp. 515–527, 2006.
View at: Publisher Site | Google Scholar
E. Charafe-Jauffret, C. Ginestier, F. Monville et al., “Gene expression profiling of breast cell lines identifies potential new basal markers,” Oncogene, vol. 25, no. 15, pp. 2273–2284, 2006.
View at: Publisher Site | Google Scholar
L. B. Eckert, G. A. Repasky, A. S. Ülkü et al., “Involvement of ras activation in human breast cancer cell signaling, invasion, and anoikis,” Cancer Research, vol. 64, no. 13, pp. 4585–4592, 2004.
View at: Publisher Site | Google Scholar
M. Lacroix, R.-A. Toillon, and G. Leclercq, “p53 and breast cancer, an update,” Endocrine-Related Cancer, vol. 13, no. 2, pp. 293–325, 2006.
View at: Publisher Site | Google Scholar
S. Vranic, Z. Gatalica, and Z.-Y. Wang, “Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies,” Oncology Letters, vol. 2, no. 6, pp. 1131–1137, 2011.
View at: Publisher Site | Google Scholar
S. A. Eccles, “The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology,” The International Journal of Developmental Biology, vol. 55, no. 7-9, pp. 685–696, 2011.
View at: Publisher Site | Google Scholar
C. Tsai, Y. Hsu, W. Chen et al., “Hepatoprotective effect of electrolyzed reduced water against carbon tetrachloride-induced liver damage in mice,” Food and Chemical Toxicology, vol. 47, no. 8, pp. 2031–2036, 2009.
View at: Publisher Site | Google Scholar
Y. Li, T. Hamasaki, N. Nakamichi et al., “Suppressive effects of electrolyzed reduced water on alloxan-induced apoptosis and type 1 diabetes mellitus,” Cytotechnology, vol. 63, no. 2, pp. 119–131, 2011.
View at: Publisher Site | Google Scholar
K.-C. Huang, C.-C. Yang, K.-T. Lee, and C.-T. Chien, “Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water,” Kidney International, vol. 64, no. 2, pp. 704–714, 2003.
View at: Publisher Site | Google Scholar
M. Nakayama, H. Nakano, H. Hamada, N. Itami, R. Nakazawa, and S. Ito, “A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: A clinical trial,” Nephrology Dialysis Transplantation , vol. 25, no. 9, pp. 3026–3033, 2010.
View at: Publisher Site | Google Scholar
T. C. Cheng, Y. W. Hsu, F. J. Lu et al., “Nephroprotective effect of electrolyzed reduced water against cisplatin-induced kidney toxicity and oxidative damage in mice,” Journal of the Chinese Medical Association, p. S1726-4901(17)30261-7, 2017.
View at: Google Scholar
S. Spulber, K. Edoff, L. Hong, S. Morisawa, S. Shirahata, and S. Ceccatelli, “Molecular hydrogen reduces lps-induced neuroinflammation and promotes recovery from sickness behaviour in mice,” PLoS ONE, vol. 7, no. 7, Article ID e42078, 2012.
View at: Publisher Site | Google Scholar
T. Kinjo, J. Ye, H. Yan et al., “Suppressive effects of electrochemically reduced water on matrix metalloproteinase-2 activities and in vitro invasion of human fibrosarcoma HT1080 cells,” Cytotechnology, vol. 64, no. 3, pp. 357–371, 2012.
View at: Publisher Site | Google Scholar
S. Franceschelli, D. Gatta, M. Pesce et al., “New Approach in Translational Medicine: Effects of Electrolyzed Reduced Water (ERW) on NF-κB/iNOS Pathway in U937 Cell Line under Altered Redox State,” International Journal of Molecular Sciences, vol. 17, no. 9, p. 1461, 2016.
View at: Publisher Site | Google Scholar
J. He, Q. Xu, Y. Jing et al., “Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation,” EMBO Reports, vol. 13, no. 12, pp. 1116–1122, 2012.
View at: Publisher Site | Google Scholar
F. Belmonte, S. Das, P. Sysa-Shah et al., “ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 309, no. 8, pp. H1271–H1280, 2015.
View at: Publisher Site | Google Scholar
W. K. Kim, M. H. Bang, E. S. Kim et al., “Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells,” The Journal of Nutritional Biochemistry, vol. 16, no. 3, pp. 155–162, 2005.
View at: Publisher Site | Google Scholar
M. Kutwin, E. Sawosz, S. Jaworski et al., “Investigation of platinum nanoparticle properties against U87 glioblastoma multiforme,” Archives of Medical Science, vol. 13, no. 6, pp. 1322–1334, 2017.
View at: Publisher Site | Google Scholar
M. Yamada, M. Foote, and T. W. Prow, “Therapeutic gold, silver, and platinum nanoparticles,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 7, no. 3, pp. 428–445, 2015.
View at: Publisher Site | Google Scholar
C. A. Pratilas and D. B. Solit, “Targeting the mitogen-activated protein kinase pathway: Physiological feedback and drug response,” Clinical Cancer Research, vol. 16, no. 13, pp. 3329–3334, 2010.
View at: Publisher Site | Google Scholar
S. Zhuang and R. G. Schnellmann, “A death-promoting role for extracellular signal-regulated kinase,” The Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 3, pp. 991–997, 2006.
View at: Publisher Site | Google Scholar
S. Cagnol and J. C. Chambard, “ERK and cell death: Mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence,” FEBS Journal, vol. 277, no. 1, pp. 2–21, 2010.
View at: Publisher Site | Google Scholar
D. Liu, Y. Huang, B. Chen et al., “Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma,” Cancer, vol. 117, no. 16, pp. 3763–3773, 2011.
View at: Publisher Site | Google Scholar
C. Rommel, B. A. Clarke, S. Zimmermann et al., “Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt,” Science, vol. 286, no. 5445, pp. 1738–1741, 1999.
View at: Publisher Site | Google Scholar
S. Zimmermann and K. Moelling, “Phosphorylation and regulation of Raf by Akt (protein kinase B),” Science, vol. 286, no. 5445, pp. 1741–1744, 1999.
View at: Publisher Site | Google Scholar
K.-L. Guan, C. Figueroa, T. R. Brtva et al., “Negative regulation of the serine/threonine kinase B-Raf by Akt,” The Journal of Biological Chemistry, vol. 275, no. 35, pp. 27354–27359, 2000.
View at: Publisher Site | Google Scholar
H. P. Reusch, S. Zimmermann, M. Schaefer, M. Paul, and K. Moelling, “Regulation of Raf by Akt Controls Growth and Differentiation in Vascular Smooth Muscle Cells,” The Journal of Biological Chemistry, vol. 276, no. 36, pp. 33630–33637, 2001.
View at: Publisher Site | Google Scholar
D. Tang, H. Okada, J. Ruland et al., “Akt Is Activated in Response to an Apoptotic Signal,” The Journal of Biological Chemistry, vol. 276, no. 32, pp. 30461–30466, 2001.
View at: Publisher Site | Google Scholar
J. H. Park, C. K. Kim, S. B. Lee, K. Lee, S. Cho, and J. Ahn, “Akt attenuates apoptotic death through phosphorylation of H2A under hydrogen peroxide-induced oxidative stress in PC12 cells and hippocampal neurons,” Scientific Reports, vol. 6, no. 1, 2016.
View at: Publisher Site | Google Scholar
S. Maddika, S. R. Ande, E. Wiechec, L. L. Hansen, S. Wesselborg, and M. Los, “Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis,” Journal of Cell Science, vol. 121, no. 7, pp. 979–988, 2008.
View at: Publisher Site | Google Scholar
Z. Hou, Y. Cui, H. Xing, and X. Mu, “Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells,” Oncology Letters, vol. 15, pp. 1943–1948, 2018.
View at: Publisher Site | Google Scholar
C. Guillouf, J.-P. Vit, and F. Rosselli, “Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation,” Biochimie, vol. 82, no. 1, pp. 51–58, 2000.
View at: Publisher Site | Google Scholar
T. Wang, C. M. Simbulan-Rosenthal, M. E. Smulson, P. B. Chock, and D. C. H. Yang, “Polyubiquitylation of PARP-1 through ubiquitin K48 is modulated by activated DNA, NAD+, and dipeptides,” Journal of Cellular Biochemistry, vol. 104, no. 1, pp. 318–328, 2008.
View at: Publisher Site | Google Scholar
S. Matsushima, N. Okita, M. Oku, W. Nagai, M. Kobayashi, and Y. Higami, “An Mdm2 antagonist, Nutlin-3a, induces p53-dependent and proteasome-mediated poly(ADP-ribose) polymerase1 degradation in mouse fibroblasts,” Biochemical and Biophysical Research Communications, vol. 407, no. 3, pp. 557–561, 2011.
View at: Publisher Site | Google Scholar
W. Nagai, N. Okita, H. Matsumoto, H. Okado, M. Oku, and Y. Higami, “Reversible induction of PARP1 degradation by p53-inducible cis-imidazoline compounds,” Biochemical and Biophysical Research Communications, vol. 421, no. 1, pp. 15–19, 2012.
View at: Publisher Site | Google Scholar
C. Lin, W. Chuang, F. Lu, and C. Chen, “Anti-oxidant and anti-inflammatory effects of hydrogen-rich water alleviate ethanol-induced fatty liver in mice,” World Journal of Gastroenterology, vol. 23, no. 27, pp. 4920–4934, 2017.
View at: Publisher Site | Google Scholar
R. L. Carpenter and H. W. Lo, “Regulation of Apoptosis by HER2 in Breast Cancer,” Journal of Carcinogenesis & Mutagenesis, 2013.
View at: Publisher Site | Google Scholar
